Synergistic Targeted Therapy of Antibody-Drug Conjugates for Triple-Negative Breast Cancer

Grant

Total Award Amount

  • 1805063.00
  • Direct Costs

  • 1297513.00
  • Sponsor Award Id

  • R01CA238273